Effect of Vandetanib Treatment on Cystic Changes in the Liver following Metastasis from Medullary Thyroid Carcinoma

A number of causes are responsible for the development of cystic lesions in the liver. However, metastasis is a rare cause, and cystic metastasis from medullary thyroid carcinoma has not yet been reported. A 46-year-old Japanese man presented to our hospital with a mass in the left side of his neck....

Full description

Saved in:
Bibliographic Details
Main Authors: Ai Matsui, Soji Toda, Daisuke Murayama, Hiroyuki Iwasaki
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Case Reports in Endocrinology
Online Access:http://dx.doi.org/10.1155/2022/9855403
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832545916870983680
author Ai Matsui
Soji Toda
Daisuke Murayama
Hiroyuki Iwasaki
author_facet Ai Matsui
Soji Toda
Daisuke Murayama
Hiroyuki Iwasaki
author_sort Ai Matsui
collection DOAJ
description A number of causes are responsible for the development of cystic lesions in the liver. However, metastasis is a rare cause, and cystic metastasis from medullary thyroid carcinoma has not yet been reported. A 46-year-old Japanese man presented to our hospital with a mass in the left side of his neck. Neck and thyroid ultrasonography revealed a thyroid tumor with calcification and enlarged cervical lymph nodes. He had a family history of medullary thyroid cancer. Computed tomography revealed a tumor in the thyroid and multiple cysts in the liver. Total thyroidectomy with modified neck and upper mediastinum dissections were performed. After surgery, vandetanib treatment was initiated owing to tumor progression; following this, the liver cysts increased in size, abdominal distension appeared, and serum liver enzyme levels were found to be elevated. Percutaneous liver cyst puncture was performed to reduce abdominal distension; however, it was ineffective. The liver enzyme levels improved after replacing vandetanib with lenvatinib treatment. The liver cysts in this case were indicated to be associated with medullary thyroid carcinoma.
format Article
id doaj-art-4dae5221b03646fc9a325de15d0e8f57
institution Kabale University
issn 2090-651X
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Case Reports in Endocrinology
spelling doaj-art-4dae5221b03646fc9a325de15d0e8f572025-02-03T07:24:18ZengWileyCase Reports in Endocrinology2090-651X2022-01-01202210.1155/2022/9855403Effect of Vandetanib Treatment on Cystic Changes in the Liver following Metastasis from Medullary Thyroid CarcinomaAi Matsui0Soji Toda1Daisuke Murayama2Hiroyuki Iwasaki3Department of Breast and Endocrine SurgeryDepartment of Breast and Endocrine SurgeryDepartment of Breast and Endocrine SurgeryDepartment of Breast and Endocrine SurgeryA number of causes are responsible for the development of cystic lesions in the liver. However, metastasis is a rare cause, and cystic metastasis from medullary thyroid carcinoma has not yet been reported. A 46-year-old Japanese man presented to our hospital with a mass in the left side of his neck. Neck and thyroid ultrasonography revealed a thyroid tumor with calcification and enlarged cervical lymph nodes. He had a family history of medullary thyroid cancer. Computed tomography revealed a tumor in the thyroid and multiple cysts in the liver. Total thyroidectomy with modified neck and upper mediastinum dissections were performed. After surgery, vandetanib treatment was initiated owing to tumor progression; following this, the liver cysts increased in size, abdominal distension appeared, and serum liver enzyme levels were found to be elevated. Percutaneous liver cyst puncture was performed to reduce abdominal distension; however, it was ineffective. The liver enzyme levels improved after replacing vandetanib with lenvatinib treatment. The liver cysts in this case were indicated to be associated with medullary thyroid carcinoma.http://dx.doi.org/10.1155/2022/9855403
spellingShingle Ai Matsui
Soji Toda
Daisuke Murayama
Hiroyuki Iwasaki
Effect of Vandetanib Treatment on Cystic Changes in the Liver following Metastasis from Medullary Thyroid Carcinoma
Case Reports in Endocrinology
title Effect of Vandetanib Treatment on Cystic Changes in the Liver following Metastasis from Medullary Thyroid Carcinoma
title_full Effect of Vandetanib Treatment on Cystic Changes in the Liver following Metastasis from Medullary Thyroid Carcinoma
title_fullStr Effect of Vandetanib Treatment on Cystic Changes in the Liver following Metastasis from Medullary Thyroid Carcinoma
title_full_unstemmed Effect of Vandetanib Treatment on Cystic Changes in the Liver following Metastasis from Medullary Thyroid Carcinoma
title_short Effect of Vandetanib Treatment on Cystic Changes in the Liver following Metastasis from Medullary Thyroid Carcinoma
title_sort effect of vandetanib treatment on cystic changes in the liver following metastasis from medullary thyroid carcinoma
url http://dx.doi.org/10.1155/2022/9855403
work_keys_str_mv AT aimatsui effectofvandetanibtreatmentoncysticchangesintheliverfollowingmetastasisfrommedullarythyroidcarcinoma
AT sojitoda effectofvandetanibtreatmentoncysticchangesintheliverfollowingmetastasisfrommedullarythyroidcarcinoma
AT daisukemurayama effectofvandetanibtreatmentoncysticchangesintheliverfollowingmetastasisfrommedullarythyroidcarcinoma
AT hiroyukiiwasaki effectofvandetanibtreatmentoncysticchangesintheliverfollowingmetastasisfrommedullarythyroidcarcinoma